PT  - JOURNAL ARTICLE
AU  - Marchesin, Marcelo
AU  - Sabeti, Mehran
TI  - ASSESSING VACCINATION STRATEGIES FOR THE COVID-19 EPIDEMIC IN MINAS GERAIS (BRAZIL)
AID  - 10.1101/2021.04.19.21255731
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.19.21255731
4099  - http://medrxiv.org/content/early/2021/04/27/2021.04.19.21255731.short
4100  - http://medrxiv.org/content/early/2021/04/27/2021.04.19.21255731.full
AB  - In this work we analyze the effectiveness of vaccination strategies for the COVID-19 epidemic in the Brazilian state of Minas Gerais. Firstly we study the effectiveness of general vaccination in the decreasing of the number of infected individuals using a traditional non structured SEIR model. Secondly we consider an age-structured SEIR model with 3 age groups (youngster, adult and elderly) and we analyze the current strategy in the Brazilian state of Minas Gerais, of focusing the vaccination on the elderly group. We conclude by showing this strategy to be mistaken and that a vaccination focusing on the age group of the adults would be much more efficient in decreasing the total number of infected individuals.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:There was no need of approval of any IRB/oversight body for the elaboration of this articleAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data used in the article has been referred to at the bilbiography and can be easily found on the corresponding website